Circulars No.7093, No.7106, No.7442, No.8044, and No.7228 for the year 2024 regarding medical devices recall and Field Safety Corrective Actions
27 Sep 2024
Reference: CIR-2024-00000177
To all Health facilities and healthcare practitioners in Dubai's private health sector
Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated
Circular No.7093 for the year 2024 Product Information Update of Medical Products Containing Active Ingredient Naproxen
Circular No.7106 for the year 2024 regarding Recall of One lot of Brukinsa 80mg
Circular No. 7442 for the year 2024 regarding notifications of Field Safety Corrective Action
Circular No.8044 for the year 2024 regarding notifications of Field Safety Corrective Action
Circular No.7228 for the year 2024 regarding notifications of Field Safety Corrective Action
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
DHA
Supporting Documents:
تقارير سلامة الوسائل الطبية0019-09-2024.pdf
downloadتقارير سلامة الوسائل الطبية +-03-09-2024.pdf
downloadتقارير سلامة الوسائل الطبية -+ 05-09-2024.pdf
downloadتحديث معلومات المنتجات الطبية التي تحتوي على المادة03.09.2024-.pdf
downloadBrukinsa 80 mg +-سحب تشغيلة واحدة من المنتج الطبي.pdf
downloadDo you find this Content helpful?